These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 2358196)

  • 1. Changes in urethral cytology following estrogen administration.
    Bergman A; Karram MM; Bhatia NN
    Gynecol Obstet Invest; 1990; 29(3):211-3. PubMed ID: 2358196
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of estrogen on urethral function in women with urinary incontinence.
    Bhatia NN; Bergman A; Karram MM
    Am J Obstet Gynecol; 1989 Jan; 160(1):176-81. PubMed ID: 2912080
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estrogen effects on the urethra: beneficial effects in women with genuine stress incontinence.
    Elia G; Bergman A
    Obstet Gynecol Surv; 1993 Jul; 48(7):509-17. PubMed ID: 8355926
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The use of intravaginal oestrogen cream in genuine stress incontinence.
    Hilton P; Stanton SL
    Br J Obstet Gynaecol; 1983 Oct; 90(10):940-4. PubMed ID: 6313035
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A randomized comparative study of the effects of oral and topical estrogen therapy on the lower urinary tract of hysterectomized postmenopausal women.
    Long CY; Liu CM; Hsu SC; Chen YH; Wu CH; Tsai EM
    Fertil Steril; 2006 Jan; 85(1):155-60. PubMed ID: 16412747
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of the urethral mucosa before and after oestrogen treatment in postmenopausal women with a new sampling technique.
    Ulmsten U; Stormby N
    Gynecol Obstet Invest; 1987; 24(3):208-11. PubMed ID: 3319819
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Effect of Vaginal Oestriol Cream on Subjective and Objective Symptoms of Stress Urinary Incontinence and Vaginal Atrophy: An International Multi-Centre Pilot Study.
    Weber MA; Lim V; Oryszczyn J; Te West N; Souget J; Jeffery S; Roovers JP; Moore KH
    Gynecol Obstet Invest; 2017; 82(1):15-21. PubMed ID: 26990867
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Is there a correlation between the degree of proliferation of vaginal and urethral epithelium and the incidence of stress incontinence? A contribution to estrogen therapy in stress incontinence].
    Schwenzer T; Buth C; Degen W; Jahn K
    Geburtshilfe Frauenheilkd; 1987 Mar; 47(3):158-64. PubMed ID: 3582922
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of combined treatment with phenylpropanolamine and estriol, compared with estriol treatment alone, in postmenopausal women with stress urinary incontinence.
    Ahlström K; Sandahl B; Sjöberg B; Ulmsten U; Stormby N; Lindskog M
    Gynecol Obstet Invest; 1990; 30(1):37-43. PubMed ID: 2227611
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estrogen therapy influence on periurethral vessels in postmenopausal incontinent women using Dopplervelocimetry analysis.
    Kobata SA; Girão MJ; Baracat EC; Kajikawa M; Di Bella V; Sartori MG; Jármy-Di Bella ZI
    Maturitas; 2008 Nov; 61(3):243-7. PubMed ID: 18845407
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The use of two estrogen preparations (a combined contraceptive pill versus conjugated estrogen cream) intravaginally to treat urogenital symptoms in postmenopausal Thai women: a comparative study.
    Chompootaweep S; Nunthapisud P; Trivijitsilp P; Sentrakul P; Dusitsin N
    Clin Pharmacol Ther; 1998 Aug; 64(2):204-10. PubMed ID: 9728901
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Usefulness of urethrocytologic studies in urinary incontinence].
    Fischer W; Hannig I
    Zentralbl Gynakol; 1985; 107(7):424-31. PubMed ID: 4039871
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Menopausal genuine stress urinary incontinence treated with conjugated estrogens plus progestogens.
    Sartori MG; Baracat EC; Girão MJ; Gonçalves WJ; Sartori JP; de Lima GR
    Int J Gynaecol Obstet; 1995 May; 49(2):165-9. PubMed ID: 7649322
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systemic effects of conjugated equine estrogen vaginal cream on bone turnover markers in postmenopausal women.
    Luengratsameerung S; Panyakhamlerd K; Treratanachat S; Taechakraichana N
    Climacteric; 2013 Feb; 16(1):133-40. PubMed ID: 22515801
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intraluminal urethral pressure measurements in the female baboon: effects of hormonal manipulation.
    Bump RC; Friedman CI
    J Urol; 1986 Aug; 136(2):508-11. PubMed ID: 3735525
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of stress incontinence with estrogen in postmenopausal women.
    Faber P; Heidenreich J
    Urol Int; 1977; 32(2-3):221-3. PubMed ID: 562018
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estrogen therapy in the management of problems associated with urogenital ageing: a simple diagnostic test and the effect of the route of hormone administration.
    Notelovitz M
    Maturitas; 1995 Dec; 22 Suppl():S31-3. PubMed ID: 8775774
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Urodynamic changes following hormonal replacement therapy in women with premature ovarian failure.
    Karram MM; Yeko TR; Sauer MV; Bhatia NN
    Obstet Gynecol; 1989 Aug; 74(2):208-11. PubMed ID: 2546111
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Measurement of urethral closure function in women with stress urinary incontinence.
    Klarskov N; Scholfield D; Soma K; Darekar A; Mills I; Lose G
    J Urol; 2009 Jun; 181(6):2628-33; discussion 2633. PubMed ID: 19375093
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Randomized comparison of tolterodine with vaginal estrogen cream versus tolterodine alone for the treatment of postmenopausal women with overactive bladder syndrome.
    Tseng LH; Wang AC; Chang YL; Soong YK; Lloyd LK; Ko YJ
    Neurourol Urodyn; 2009; 28(1):47-51. PubMed ID: 19089890
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.